STIM Neuronetics, Inc.
Healthcare$1.20+0.84%ClosedMarket Cap: $83.5M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
6.30
P/S
0.55
EV/EBITDA
-3.61
DCF Value
$-49.60
FCF Yield
-16.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.0%
Operating Margin
-19.4%
Net Margin
-24.5%
ROE
-164.7%
ROA
-29.6%
ROIC
-28.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $34.5M | 46.9% | $-9.0M | $-10.8M | $— | — |
| Q4 null | $41.8M | 52.0% | $-5.0M | $-7.2M | $— | — |
| FY null | $149.2M | 48.5% | $-31.4M | $-39.0M | $— | — |
| Q3 null | $37.3M | 45.9% | $-7.3M | $-9.0M | $— | — |
| Q2 null | $38.1M | 46.6% | $-8.1M | $-10.1M | $— | — |
| Q1 null | $32.0M | 49.2% | $-11.0M | $-12.7M | $— | — |
| Q4 null | $22.5M | 66.2% | $-11.5M | $-12.7M | $— | — |
| FY null | $74.9M | 72.3% | $-34.6M | $-43.7M | $— | — |
| Q3 null | $18.5M | 75.6% | $-7.7M | $-13.3M | $— | — |
| Q2 null | $16.4M | 74.0% | $-8.5M | $-9.8M | $— | — |
| Q1 null | $17.4M | 75.1% | $-6.9M | $-7.9M | $— | — |
| Q4 2023 | $20.3M | 77.6% | $-4.4M | $-5.4M | $-0.19 | — |